medigraphic.com
Colegio de Medicos y Cirujanos República de Costa Rica

2016, Number 619

<< Back Next >>

Rev Med Cos Cen 2016; 73 (619)

Manejo de pacientes con herpes zoster

Brenes NR

Language: Spanish
References: 27
Page: 255-260
PDF size: 198.47 Kb.


ABSTRACT

Herpes zoster (HZ) is an infectious disease that despite being self-limiting can leave serious sequelae in the host with some degree of immunocompromised, also herpes zoster is a frequent cause of visits to health services in our country.


REFERENCES

  1. Arenas, Roberto. Dermatología: atlas, diagnóstico y tratamiento. Tercera edición. México DF: Editorial McGraw-Hill; 2005: 545- 547.

  2. Beutner KR, Friedman DJ, Froszpaniak C, Andersen PL, Wood MJ. Valaciclovir compared whit acyclovir for improved therapy for herpes zoster in the immunocompetent adults. Antimicrob Agents Chemother 1995; 39(7): 1546-1553.

  3. Choo PW, Galil K, Donahue JG, Walker AM, Spiegelman D, Platt R. Risk factors of postherpetic neuralgia. Arch Intern Med 1997; 157 (11):1217- 1224.

  4. Degreef H. Famciclovir, a new oral antiherpes zoster drug. Results of the first clinical study demonstrating its efficacy and safety in the treatment of uncomplicated herpes zoster in immunocompetent patients. Int J Antimicrob Agents.1994; 4: 241-246

  5. Dennis L. Kasper, Anthony S. Fauci, Dan L. Longo, Eugene Braunwald, Stephen L. Hauser y J. Larry Jameson Harrison: Principios de medicina interna. México, DF: Editorial McGraw-Hill Interamericana; 2005: 1159- 1162.

  6. Fitzpatrick TB, Eisen AZ, Wolf K, Freedberg IM, Austen KF. Dermatologíaen Medicina General. Cuarta Edición. Buenos Aires, Argentina: Editorial Médica Panamericana; 1997: 2641-2671.

  7. Flores J, Armijo JA, Mediavilla A. Farmacología humana. Tercera Edición. Barcelona España: Editorial MASSON 1997; 1187-1199.

  8. Formulario Terapéutico Institucional. Caja Costarricense de Seguro Social 2004; 12-17

  9. Ghann JW Jr, Whitley RJ. Herpes zoster. N.England Med 2002; 347 (5): 340-346.

  10. Harrison. Principios de Medicina Interna. Volumen 1. Edición 18 McGraw-Hill. 2012. Páginas 1464- 1466

  11. Johnson RW and Dworkin RH. Treatment of herpes zoster and postherpetica neuralgia. BMJ 2003; 326:748–50.

  12. Katzung Bertran G. Terapéutica clínica. Novena edición. México, DF: Editorial El Manual Moderno; 2005: 793-818.

  13. McKendrick MW, McGill JI, White JE, Wood MJ. Oral Aciclovir in acute herpes zoster. British Medical Journal 1986; 293:1529-1532

  14. Moya Mir MS, Cadavid CM. Herpes zoster en urgencias. Emergencias 2005; 17: 75-84.

  15. Morton P, Thomson AN. Oral acyclovir in the treatment of herpes zoster in general practice. N. Z Med J 1989; 102:93-5.

  16. Mounsey AL, Matthew LG and Slawson DC. Herpes Zoster and Postherpetic Neuralgia: Prevention and Management. Am Fam Physician 2005; 72: 1075-80, 1082.

  17. Murray PR, Kobayashi GS, Pfaller MA, Rosenthal KS. Microbiología médica. Segunda Edición. Madrid, España: Ediciones Harcourt; 2002: 571- 583.

  18. Perry CM, Wagstaff AJ. Famciclovir. A review of its pharmacological properties and therapeutic efficacy in Herpesvirus infections. Drugs1995; 50:396-415.

  19. Tenser R B and Dworkin RH. Herpes zoster and the prevention of postherpetic neuralgia beyond antiviral therapy. Neurology 2005; 65: 349– 350.

  20. Tyring S, Barbarash RA, Nahlik JE, Cunningham A, Marley J, Heng M, Jones T, Rea T, Boon R, Saltzman R. Famciclovir for the treatment of acute herpes zoster: effects on acute disease and postherpetic neuralgia. A randomized, double-blind, placebocontrolled trial. Collaborative Famciclovir Herpes Zoster Study Group. Ann Intern Med 1995; 123:89-96.

  21. Tyring S, Barbarash RA, Nahlik JM, Cunningham A, Marley John, Heng M, Jones T, Rea T, Boon R, Saltzman R. Efficacy of famciclovir in the treatment of herpes zoster: reduction of pain associated with zoster. Neurology 1995; 45 suppl 8:76.

  22. Tyring SK, Beutner KR, Tucker BA, Anderson WC, Crooks RJ. Antiviral therapy for herpes zoster: randomized, controlled clinical trial of valacyclovir and famciclovir therapy in immunocompetent patients 50 years and older. Arch Fam Med 2000; 9:863-869

  23. Whitley RJ, Weiss H. L,. Soong S. J, Gnann J. W. Herpes Zoster: Risk Categories for Persistent Pain. The Journal of Infectious Diseases 1999; 179:9–15.

  24. Wood MJ, Ogan PH, McKendrick, Care CD, McGill JI, Webb EM. Efficacy of oral acyclovir treatment of acute herpes zoster. Am J Med 1988; 85:79-83

  25. Wood MJ, Kay R, Dworkin RH, Soong SJ, Whitley RJ. Oral Acyclovir Therapy Accelerates Pain Resolution in Patients with Herpes Zoster: a metaanalisis of placebo –controlled trials. Clin Infect Dis. 1996; 22: 341-347.

  26. Wood JJ, Kost RG, Straus SE. Postherpetic neuralgia, pathogenesis, treatment, and prevention. The New England Journal of Medicine 1996; 335: 32-42.

  27. Zurro A. Martin, Cano Pérez J.F. Atención Primaria. Conceptos, organización y práctica clínica. Tercera Edición. ELSEVIER. 2010. Páginas 812.




2020     |     www.medigraphic.com